مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in healthy subjects.

Authors : Hwang I; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.; Ji SC

Subjects: Potassium* ; Esomeprazole*; Humans

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 763-772. Date of Electronic Publication: 2023 Feb 02.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A population PK-PD model of YH4808, a novel P-CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808.

Authors : Chung TK; Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.; Lee HA

Subjects: Anti-Ulcer Agents* ; Esomeprazole*/Esomeprazole*/Esomeprazole*/analogs & derivatives ; Esomeprazole*/Esomeprazole*/Esomeprazole*/pharmacokinetics

Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2022 Sep; Vol. 11 (9), pp. 1223-1233. Date of Electronic Publication: 2022 Jul 09.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Evaluation of the Pharmacokinetic Interaction and Safety of Ubrogepant Coadministered With Esomeprazole Magnesium.

Authors : Boinpally R; AbbVie, Madison, New Jersey, USA.; Lu K

Subjects: Esomeprazole*/Esomeprazole*/Esomeprazole*/administration & dosage ; Esomeprazole*/Esomeprazole*/Esomeprazole*/adverse effects ; Esomeprazole*/Esomeprazole*/Esomeprazole*/pharmacokinetics

Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2022 Feb; Vol. 11 (2), pp. 270-277. Date of Electronic Publication: 2021 Nov 22.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

The impacts of acid suppression on duodenal microbiota during the early phase of severe acute pancreatitis.

Authors : Ma X; Laboratory of Gastroenterology and Hepatology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, People's Republic of China.; Huang L

Subjects: Acids/Acids/Acids/*metabolism ; Anti-Ulcer Agents/Anti-Ulcer Agents/Anti-Ulcer Agents/*pharmacology ; Duodenum/Duodenum/Duodenum/*drug effects

Source: Scientific reports [Sci Rep] 2020 Nov 18; Vol. 10 (1), pp. 20063. Date of Electronic Publication: 2020 Nov 18.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Population pharmacokinetic analysis of esomeprazole in Japanese subjects with various CYP2C19 phenotypes.

Authors : Nagase M; Quantitative Clinical Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA.; Shimada H

Subjects: Models, Biological*; Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/Cytochrome P-450 CYP2C19/*metabolism ; Esomeprazole/Esomeprazole/Esomeprazole/*pharmacokinetics

Source: Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2020 Oct; Vol. 45 (5), pp. 1030-1038. Date of Electronic Publication: 2020 Mar 30.Publisher: Country of Publication: England NLM ID: 8704308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2710

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography-tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazole.

Authors : Dionísio TJ; Biological Sciences, Bauru School of Dentistry, University of São Paulo, São Paulo, Brazil.; Oliveira GM

Subjects: Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/*pharmacokinetics ; Drug Monitoring/Drug Monitoring/Drug Monitoring/*methods ; Esomeprazole/Esomeprazole/Esomeprazole/*pharmacokinetics

Source: PloS one [PLoS One] 2020 Aug 11; Vol. 15 (8), pp. e0236297. Date of Electronic Publication: 2020 Aug 11 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Comparison between esomeprazole 20 mg Vs 40 mg as stress ulcer prophylaxis (SUP) in critically ill patients: A retrospective cohort study.

Authors : Al Sulaiman K; Pharmaceutical Care Department-King Abdulaziz Medical City-MNGHA, King Abdullah International Medical Research Center/King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Al Aamer K

Subjects: Anti-Ulcer Agents/Anti-Ulcer Agents/Anti-Ulcer Agents/*administration & dosage ; Esomeprazole/Esomeprazole/Esomeprazole/*administration & dosage ; Gastrointestinal Hemorrhage/Gastrointestinal Hemorrhage/Gastrointestinal Hemorrhage/*prevention & control

Source: Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Aug; Vol. 8 (4), pp. e00624.Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A comparative study of the effect of 10-day esomeprazole containing levofloxacin versus clarithromycin sequential regimens on the treatment of Iranian patients with Helicobacter pylori infection.

Authors : Mokhtare M; Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.; Nikkhah M

Subjects: Helicobacter pylori*; Esomeprazole/Esomeprazole/Esomeprazole/*therapeutic use ; Helicobacter Infections/Helicobacter Infections/Helicobacter Infections/*drug therapy

Source: Indian journal of pharmacology [Indian J Pharmacol] 2020 Jul-Aug; Vol. 52 (4), pp. 266-271.Publisher: Medknow Publications Country of Publication: India NLM ID: 7902477 Publication Model: Print Cited Medium: Internet ISSN: 1998-3751

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Esomeprazole fixed drug eruption.

Authors : Salloum A; Department of Dermatology, Saint Georges Hospital University Medical Center, Beirut, Lebanon.; Nasr D

Subjects: Drug Eruptions/Drug Eruptions/Drug Eruptions/*etiology ; Esomeprazole/Esomeprazole/Esomeprazole/*adverse effects ; Proton Pump Inhibitors/Proton Pump Inhibitors/Proton Pump Inhibitors/*adverse effects

Source: Contact dermatitis [Contact Dermatitis] 2020 May; Vol. 82 (5), pp. 334-335. Date of Electronic Publication: 2020 Feb 17.Publisher: Wiley Country of Publication: England NLM ID: 7604950 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0536

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A comparative study of the efficacy of NAXOZOL compared to celecoxib in patients with osteoarthritis.

Authors : Park MS; Department of Orthopaedic Surgery, Medical College of Hallym University, Gyeonggi-do, Republic of Korea.; Kang CN

Subjects: Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use ; Celecoxib/Celecoxib/Celecoxib/*therapeutic use ; Esomeprazole/Esomeprazole/Esomeprazole/*therapeutic use

Source: PloS one [PLoS One] 2020 Jan 27; Vol. 15 (1), pp. e0226184. Date of Electronic Publication: 2020 Jan 27 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in healthy subjects.

A population PK-PD model of YH4808, a novel P-CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808.

Evaluation of the Pharmacokinetic Interaction and Safety of Ubrogepant Coadministered With Esomeprazole Magnesium.

The impacts of acid suppression on duodenal microbiota during the early phase of severe acute pancreatitis.

Population pharmacokinetic analysis of esomeprazole in Japanese subjects with various CYP2C19 phenotypes.

Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography-tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazole.

Comparison between esomeprazole 20 mg Vs 40 mg as stress ulcer prophylaxis (SUP) in critically ill patients: A retrospective cohort study.

A comparative study of the effect of 10-day esomeprazole containing levofloxacin versus clarithromycin sequential regimens on the treatment of Iranian patients with Helicobacter pylori infection.

Esomeprazole fixed drug eruption.

A comparative study of the efficacy of NAXOZOL compared to celecoxib in patients with osteoarthritis.

اتصل بنا

اتبع